PHARMA PATENTS GRANTED DURING 2010-11 TO 2013-14 ( UP TO 31-7-2013) Application No Date of Filing Patent No Patent Grant Date Title Applicant 1074/MUM/2006 07-07-2006 239822…
1. Atreyi Banerjee Pipeline products in Phase III 2. Introduction Major mechanism of action End points employed in clinical trials Duration of trials Route of administration…
G-Protein-Coupled Receptor (GPCR): Structure and Function Yun Huang The largest family of integral membrane protein involved in many biological process and pathologies; 50%…
Inactivating mutations in the insulin receptor results in extreme insulin resistance. The resulting hyperglycemia is very difficult to treat, and patients are at risk for